Study of AZD0754 in Participants with Metastatic Prostate Cancer

Trial Identifier: D9660C00001
Sponsor: AstraZeneca
NCTID:: NCT06267729
Start Date: March 2024
Primary Completion Date: May 2027
Study Completion Date: May 2027
Condition: Prostate Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AU East Melbourne, AU, 3002
US, CA Duarte, CA, US, 91010
US, FL Tampa, FL, US, 33612
US, GA Atlanta, GA, US, 30322
US, MO Saint Louis, MO, US, 63110
US, NJ Hackensack, NJ, US, 07601
US, NY New York, NY, US, 10065
US, PA Philadelphia, PA, US, 19104
US, TX Houston, TX, US, 77030